Alexandria Real Estate Equities, Inc. (ARE)

NYSE - Nasdaq Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

206.56+0.81 (+0.39%)

At close: 4:00PM EDT

206.56 0.00 (0.00%)
After hours: 04:49PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Head and Shoulders Bottom

View all chart patterns

Performance Outlook

Previous Close	205.75
Open	206.35
Bid	206.44 x 1100
Ask	209.00 x 1100
Day's Range	205.02 - 207.07
52 Week Range	150.08 - 209.76
Volume	451,798
Avg. Volume	675,780

Market Cap	31.472B
Beta (5Y Monthly)	0.76
PE Ratio (TTM)	31.05
EPS (TTM)	6.65
Earnings Date	Oct 25, 2021
Forward Dividend & Yield	4.48 (2.18%)
Ex-Dividend Date	Sep 29, 2021
1y Target Est	217.14

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Near Fair Value

10% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ARE

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Alexandria Real Estate Equities
ARE: Raising target price to $205.00ALEXANDRIA REAL ESTATE EQUIT has an Investment Rating of HOLD; a target price of $205.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
8 days agoArgus Research

All

News

Press Releases

Research Reports

GlobeNewswire
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Einstein College of Medicine to Support Development of Novel Therapeutics
Mentorship Program Designed to Support Researchers and Clinical Scientists in Streamlining Translation of Novel Discoveries into New Therapeutic Candidates Pitch Contest to Award Winners Funding to Further Research Programs NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Orange Grove Bio, AlleyCorp and Alexandria Venture Investments, three industry leaders dedicated to the acceleration and growth of innovative healthcare and life science companies, today announced the formation of a partnership prog
Zacks
What's in Store for Alexandria (ARE) This Earnings Season?
Alexandria's (ARE) Q3 results will likely reflect benefits of having premium properties in strategic cluster locations and creditworthy tenants.
PR Newswire
Alexandria Venture Investments Maintains Recognition as #1 Most Active Early-Stage Life Science Investor
Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE:ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life science, agtech and technology campuses in AAA innovation cluster locations, was recognized by Silicon Valley Bank in its Healthcare Investments and Exits: Mid-Year 2021 Report as the #1 most active biopharma corporate investor by new deal